|
|
Dextrans - Chemistry
Research News and Information
Definition of 'Dextrans'A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes. Common names: Dextrans; Rheopolyglucin; Dextran; Dextran 40; Dextran 40000; Dextran 70; Dextran 75; Dextran 80; Dextran B-1355-S; Dextran B 1355 S; Dextran B1355; Dextran B-1355; Dextran B 1355; Dextran B512; Dextran M 70; Dextran T 70; Dextran T-40; Dextran T 40; Dextran T-500; Dextran T 500; Hemodex; Hyskon |
Sunday, November 22, 2009
Tissue responses to novel tissue engineering biodegradable cryogel scaffolds: an animal model.
29 Sep 2009
Biodegradable macroporous cryogels with highly open and interconnected pore structures were produced from dextran modified with oligo L-lactide bearing hydroxyethylmethacrylate (HEMA) end groups in moderately frozen solutions. Tissue responses to ... Read more...
Nonadditive effects of mixed crowding on protein stability.
29 Sep 2009
The crowded environments inside cells can have significant effects on the folding stability and other biophysical properties of proteins. In this study on how macromolecular crowding affects protein folding, we took a significant step toward ... Read more...
Matrix therapy in regenerative medicine, a new approach to chronic wound healing.
30 Aug 2009
Nonhealing wounds remain a major health problem whose treatment is challenging and costly. Treatments based on cells or growth factors are still not very effective. We developed an entirely novel strategy consisting in treatment of the wound-tissue ... Read more...
Latest indexed articles for 'Dextrans - Chemistry'
These are the very latest articles for this heading:
- Tissue responses to novel tissue engineering biodegradable cryogel scaffolds: an animal model.
29 Sep 2009 - Nonadditive effects of mixed crowding on protein stability.
29 Sep 2009 - Matrix therapy in regenerative medicine, a new approach to chronic wound healing.
30 Aug 2009 - Stable oil-in-water emulsions prepared from soy protein-dextran conjugates.
30 Aug 2009 - The effect of bulking agents on the chemical stability of acid-sensitive compounds in freeze-dried formulations: sucrose inversion study.
30 Aug 2009 - Temperature scanning FTIR analysis of secondary structures of proteins embedded in amorphous sugar matrix.
30 Aug 2009 - Patterning: Cells nourished by nanodrops.
30 Aug 2009 - Dielectric properties of thermo-reversible hydrogels: the case of a dextran copolymer grafted with poly(N-isopropylacrylamide).
18 Aug 2009 - Effect of dynamic loading on the transport of solutes into agarose hydrogels.
17 Aug 2009 - In vivo Ca2+ imaging of mushroom body neurons during olfactory learning in the honey bee.
16 Aug 2009 - Effect of macromolecular crowding on protein binding stability: modest stabilization and significant biological consequences.
3 Aug 2009 - Common crowding agents have only a small effect on protein-protein interactions.
3 Aug 2009 - Influence of different polymer types on the overall release mechanism in hydrophilic matrix tablets.
22 Jul 2009 - Mechanism of introduction of exogenous genes into cultured cells using DEAE-dextran-MMA graft copolymer as non-viral gene carrier.
21 Jul 2009 - Layer-by-layer deposition of polymeric microgel films on surgical sutures for loading and release of ibuprofen.
19 Jul 2009 - Dynamic light-activated control of local chemical concentration in a fluid.
13 Jul 2009 - The effects of common solubilizing agents on the intestinal membrane barrier functions and membrane toxicity in rats.
21 Jun 2009 - Parvovirus induced alterations in nuclear architecture and dynamics.
15 Jun 2009 - Fast-responsive porous thermoresponsive microspheres for controlled delivery of macromolecules.
4 Jun 2009 - Self-assembly of ibuprofen and bovine serum albumin-dextran conjugates leading to effective loading of the drug.
31 May 2009
See a longer list of these articles.
Technical information about 'Dextrans'
Definition: A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes.
Registry Number: 9004-54-0
Descriptor UI: D003911
Alternative terms: Dextrans; Rheopolyglucin; Dextran; Dextran 40; Dextran 40000; Dextran 70; Dextran 75; Dextran 80; Dextran B-1355-S; Dextran B 1355 S; Dextran B1355; Dextran B-1355; Dextran B 1355; Dextran B512; Dextran M 70; Dextran T 70; Dextran T-40; Dextran T 40; Dextran T-500; Dextran T 500; Hemodex; Hyskon; Infukoll; Macrodex; Polyglucin; Promit; Rheodextran; Rheoisodex; Rheomacrodex; Rondex; Saviosol;
Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists; ultrastructure;
Pharmacological Action: Anticoagulants; Plasma Substitutes;
Tree Number: D05.750.078.562.272; D09.698.365.272;
Online Note: use DEXTRANS to search DEXTRAN 1966-78
History Note: 79; was DEXTRAN 1963-78